{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-24-000004","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2024-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.363116+00:00","generated_at":"2026-06-06T19:02:30.289360+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Charles River Labs appoints Reshema Kemps-Polanco to board; board expands to 12","bullets":["Board increased from 11 to 12; Kemps-Polanco appointed effective Jan 22, 2024.","She will serve on Compensation Committee and Strategic Planning and Capital Allocation Committee.","Received initial pro-rata equity award valued at $255,500 in RSUs and stock options.","Kemps-Polanco is EVP and Chief Commercial Officer of Novartis US with 25 years pharma experience.","No material transactions or arrangements with Kemps-Polanco requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-24-000004","json":"https://secwatch.observer/filing/0001100682-24-000004.json","markdown":"https://secwatch.observer/filing/0001100682-24-000004.md","text":"https://secwatch.observer/filing/0001100682-24-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/0001100682-24-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/crl-20240122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T19:02:30.289360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"782141013d","claim":"Reshema Kemps-Polanco was appointed as Director at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"Following the size increase of the Board, the Board filled the vacancy and appointed Ms. Reshema Kemps-Polanco to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068224000004/0001100682-24-000004-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}